$VRX Company News Reading Wall Street’s tea le
Post# of 89355
Posted On: 12/16/2013 11:52:08 AM
$VRX Company News
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
S&P 500 hesitates at major resistance 12:31 p.m. Nov. 12, 2013 - Michael Ashbaugh
S&P 500 hesitates at major resistance 12:16 p.m. Nov. 12, 2013 - Michael Ashbaugh
Valeant swings to loss as costs overshadow revenue 6:11 a.m. Oct. 31, 2013 - MarketWatch.com
Valeant to pay Anacor $142.5 mln to settle dispute 8:42 a.m. Oct. 28, 2013 - MarketWatch.com
Julian Robertson's top stock picks 1:47 p.m. Aug. 15, 2013 - Insider Monkey
Insiders are busy buying these stocks 2:38 p.m. Aug. 14, 2013 - Insider Monkey
Private-equity firms take the money and run 5:15 a.m. Aug. 9, 2013 - Howard Gold
Valeant swings to Q2 profit as revenue rises 34% 9:39 a.m. Aug. 7, 2013 - MarketWatch.com
Julian Robertson's long-term stock picks 7:09 a.m. July 22, 2013 - Insider Monkey
Hospitals, drug firms, device makers win with Obamacare, analyst says 7:43 a.m. July 17, 2013 - Russ Britt
S&P back for another crack at major resistance 11:08 a.m. July 2, 2013 - Michael Ashbaugh
S&P back for another crack at major resistance 10:48 a.m. July 2, 2013 - Michael Ashbaugh
Valeant raises $2 billion in stock offering 3:06 a.m. June 19, 2013 - MarketWatch.com
What are insiders buying these days? 11:47 a.m. June 18, 2013 - Insider Monkey
Charting a resilient bull market 10:56 a.m. June 11, 2013 - Michael Ashbaugh
Charting a resilient bull market 10:50 a.m. June 11, 2013 - Michael Ashbaugh
Lone Pine Capital's new stock picks 10:43 a.m. May 31, 2013 - Insider Monkey
Merger Tuesday: A tally of the gains as three deals come to fruition 5:04 p.m. May 28, 2013 - Russ Britt
Valeant agrees to buy Bausch & Lomb in deal worth $8.7 billion 10:28 a.m. May 28, 2013 - Russ Britt
Valeant snaps up Solta Medical 8:29 a.m. Today - Seeking Alpha
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:36 p.m. Dec. 13, 2013 - CNW Group
Drug Stock Valeant Shapes Base With 115.50 Buy Point 4:51 p.m. Dec. 13, 2013 - Investors Business Daily
Anacor Pharmaceuticals: The Run Can Continue 12:07 p.m. Dec. 12, 2013 - Seeking Alpha
4 Stocks Advancing The Health Care Sector 12:03 p.m. Dec. 9, 2013 - TheStreet.com
Valeant Pharmaceuticals International Inc (VRX): Today's Featured Drugs Laggard 5:02 p.m. Dec. 4, 2013 - TheStreet.com
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - CNW Group
Align, Several Other IBD 50 Stocks Work On Flat Bases 5:27 p.m. Nov. 29, 2013 - Investors Business Daily
Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside 10:00 a.m. Nov. 28, 2013 - Seeking Alpha
Valeant, Las Vegas Sands Among Leaders In Buy Areas 3:48 p.m. Nov. 27, 2013 - Investors Business Daily
5 Stocks Dragging The Drugs Industry Downward 12:04 p.m. Nov. 26, 2013 - TheStreet.com
Big Cap 20: Valeant, Las Vegas Sands Form Flat Bases 5:20 p.m. Nov. 25, 2013 - Investors Business Daily
Valeant Pharmaceuticals Announces New Management Appointment 8:01 a.m. Nov. 25, 2013 - CNW Group
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
Insider Trading Alert - CYBX, VRX, CSCO, NATI And STI Traded By Insiders 11:48 a.m. Nov. 21, 2013 - TheStreet.com
Canadian Acquisitions: QLT Inc. Fits The Trend 11:45 a.m. Nov. 21, 2013 - Seeking Alpha
Shire Bolstering Its Rare Diseases Business 5:08 p.m. Nov. 20, 2013 - Investors Business Daily
Teva surges on upgrade, merger rumors 3:15 p.m. Nov. 20, 2013 - Seeking Alpha
Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes 5:01 p.m. Nov. 15, 2013 - CNW Group
SOLTA MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 34 min ago - BusinessWire
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash 8:00 a.m. Today - PR Newswire
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:35 p.m. Dec. 13, 2013 - PR Newswire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's 8:00 a.m. Dec. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Valeant Pharmaceuticals Announces New Management Appointment 8:00 a.m. Nov. 25, 2013 - PR Newswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes 5:00 p.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu® Cream, 1% 8:00 a.m. Nov. 15, 2013 - PR Newswire
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 7:31 a.m. Nov. 15, 2013 - PR Newswire
Successful Acquisitions, Declared Dividends, Stock Price Movements, Upcoming Conferences and Expansions - Research Report on Walgreens, AmerisourceBergen, GNC, Valeant Pharmaceuticals, and Omnicare 8:00 a.m. Nov. 14, 2013 - PR Newswire
Financial Results, Upcoming Presentations, and Stock Price Movements - Research Report on Valeant Pharmaceuticals, St. Jude Medical, AstraZeneca, Stryker, and Smith & Nephew 8:00 a.m. Nov. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:00 a.m. Oct. 31, 2013 - PR Newswire
Arbitration Awards, Shareholder Meetings, Marketing Agreements, New Appointments and Upcoming Earnings Schedules - Research Report on Valeant, Perrigo, IDEXX, Auxilium, and PerkinElmer 9:00 a.m. Oct. 30, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Settlement Agreement With Anacor 8:00 a.m. Oct. 28, 2013 - PR Newswire
Reading Wall Street’s tea leaves 2:44 p.m. Dec. 6, 2013 - The Trading Deck
S&P 500 hesitates at major resistance 12:31 p.m. Nov. 12, 2013 - Michael Ashbaugh
S&P 500 hesitates at major resistance 12:16 p.m. Nov. 12, 2013 - Michael Ashbaugh
Valeant swings to loss as costs overshadow revenue 6:11 a.m. Oct. 31, 2013 - MarketWatch.com
Valeant to pay Anacor $142.5 mln to settle dispute 8:42 a.m. Oct. 28, 2013 - MarketWatch.com
Julian Robertson's top stock picks 1:47 p.m. Aug. 15, 2013 - Insider Monkey
Insiders are busy buying these stocks 2:38 p.m. Aug. 14, 2013 - Insider Monkey
Private-equity firms take the money and run 5:15 a.m. Aug. 9, 2013 - Howard Gold
Valeant swings to Q2 profit as revenue rises 34% 9:39 a.m. Aug. 7, 2013 - MarketWatch.com
Julian Robertson's long-term stock picks 7:09 a.m. July 22, 2013 - Insider Monkey
Hospitals, drug firms, device makers win with Obamacare, analyst says 7:43 a.m. July 17, 2013 - Russ Britt
S&P back for another crack at major resistance 11:08 a.m. July 2, 2013 - Michael Ashbaugh
S&P back for another crack at major resistance 10:48 a.m. July 2, 2013 - Michael Ashbaugh
Valeant raises $2 billion in stock offering 3:06 a.m. June 19, 2013 - MarketWatch.com
What are insiders buying these days? 11:47 a.m. June 18, 2013 - Insider Monkey
Charting a resilient bull market 10:56 a.m. June 11, 2013 - Michael Ashbaugh
Charting a resilient bull market 10:50 a.m. June 11, 2013 - Michael Ashbaugh
Lone Pine Capital's new stock picks 10:43 a.m. May 31, 2013 - Insider Monkey
Merger Tuesday: A tally of the gains as three deals come to fruition 5:04 p.m. May 28, 2013 - Russ Britt
Valeant agrees to buy Bausch & Lomb in deal worth $8.7 billion 10:28 a.m. May 28, 2013 - Russ Britt
Valeant snaps up Solta Medical 8:29 a.m. Today - Seeking Alpha
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:36 p.m. Dec. 13, 2013 - CNW Group
Drug Stock Valeant Shapes Base With 115.50 Buy Point 4:51 p.m. Dec. 13, 2013 - Investors Business Daily
Anacor Pharmaceuticals: The Run Can Continue 12:07 p.m. Dec. 12, 2013 - Seeking Alpha
4 Stocks Advancing The Health Care Sector 12:03 p.m. Dec. 9, 2013 - TheStreet.com
Valeant Pharmaceuticals International Inc (VRX): Today's Featured Drugs Laggard 5:02 p.m. Dec. 4, 2013 - TheStreet.com
Valeant, Akorn Power Drugmakers Up IBD Industry Ranks 4:59 p.m. Dec. 3, 2013 - Investors Business Daily
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - CNW Group
Align, Several Other IBD 50 Stocks Work On Flat Bases 5:27 p.m. Nov. 29, 2013 - Investors Business Daily
Accelerated Adoption Of Iridex's MicroPulse Technology Could Lead To 100% Upside 10:00 a.m. Nov. 28, 2013 - Seeking Alpha
Valeant, Las Vegas Sands Among Leaders In Buy Areas 3:48 p.m. Nov. 27, 2013 - Investors Business Daily
5 Stocks Dragging The Drugs Industry Downward 12:04 p.m. Nov. 26, 2013 - TheStreet.com
Big Cap 20: Valeant, Las Vegas Sands Form Flat Bases 5:20 p.m. Nov. 25, 2013 - Investors Business Daily
Valeant Pharmaceuticals Announces New Management Appointment 8:01 a.m. Nov. 25, 2013 - CNW Group
Jazz, Salix Secure Drugmakers' Hold On Leadership 4:49 p.m. Nov. 21, 2013 - Investors Business Daily
Insider Trading Alert - CYBX, VRX, CSCO, NATI And STI Traded By Insiders 11:48 a.m. Nov. 21, 2013 - TheStreet.com
Canadian Acquisitions: QLT Inc. Fits The Trend 11:45 a.m. Nov. 21, 2013 - Seeking Alpha
Shire Bolstering Its Rare Diseases Business 5:08 p.m. Nov. 20, 2013 - Investors Business Daily
Teva surges on upgrade, merger rumors 3:15 p.m. Nov. 20, 2013 - Seeking Alpha
Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes 5:01 p.m. Nov. 15, 2013 - CNW Group
SOLTA MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 34 min ago - BusinessWire
Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash 8:00 a.m. Today - PR Newswire
Valeant Pharmaceuticals To Hold Conference Call To Announce 2014 Financial Guidance 6:35 p.m. Dec. 13, 2013 - PR Newswire
RBCC and Therakine Initiate Phase II of Drug Delivery Development 5:00 a.m. Dec. 12, 2013 - BusinessWire
Stock Market Dailies: Teva Pharma Industries, Dynavax Technologies, Covidien, and Valeant Pharma Intl. 10:22 a.m. Dec. 11, 2013 - PR Newswire
Stock Price Movement and Senior Notes Redemption - Research Report on Valeant, Edwards Lifesciences, Alkermes, Mallinckrodt, and Dr. Reddy's 8:00 a.m. Dec. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Redemption Of The Remaining $465.5 Million Aggrerate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Dec. 2, 2013 - PR Newswire
Product Recalls, New Appointments, Awareness Campaigns, and Stock Price Movements - Research Report on Abbott, AbbVie, Viropharma, Valeant Pharmaceuticals, and Salix Pharmaceuticals 8:00 a.m. Dec. 2, 2013 - PR Newswire
Valeant Pharmaceuticals Announces New Management Appointment 8:00 a.m. Nov. 25, 2013 - PR Newswire
Approved Acquisition, FDA Approvals, Senior Note Offerings, and Announcements by Drug Delivery Companies - Research Report on Elan, IntelliPharmaCeutics, Valeant Pharmaceuticals, Hospira, and Alkermes 8:00 a.m. Nov. 22, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Pricing Of Private Offering Of Senior Notes 5:00 p.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announced Redemption Of $450 Million Aggregate Principal Amount Of Its Outstanding 6.50% Senior Notes Due 2016 5:00 p.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announces U.S. Approval Of Luzu® Cream, 1% 8:00 a.m. Nov. 15, 2013 - PR Newswire
Technical Study: Teva Pharma Industries Ltd, Covidien PLC, Dynavax Technologies Corp., and Valeant Pharma Intl. Inc. 8:00 a.m. Nov. 15, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Launch Of Private Offering Of Senior Notes 7:31 a.m. Nov. 15, 2013 - PR Newswire
Successful Acquisitions, Declared Dividends, Stock Price Movements, Upcoming Conferences and Expansions - Research Report on Walgreens, AmerisourceBergen, GNC, Valeant Pharmaceuticals, and Omnicare 8:00 a.m. Nov. 14, 2013 - PR Newswire
Financial Results, Upcoming Presentations, and Stock Price Movements - Research Report on Valeant Pharmaceuticals, St. Jude Medical, AstraZeneca, Stryker, and Smith & Nephew 8:00 a.m. Nov. 6, 2013 - PR Newswire
Valeant Pharmaceuticals Reports 2013 Third Quarter Financial Results 6:00 a.m. Oct. 31, 2013 - PR Newswire
Arbitration Awards, Shareholder Meetings, Marketing Agreements, New Appointments and Upcoming Earnings Schedules - Research Report on Valeant, Perrigo, IDEXX, Auxilium, and PerkinElmer 9:00 a.m. Oct. 30, 2013 - PR Newswire
Valeant Pharmaceuticals Announces Settlement Agreement With Anacor 8:00 a.m. Oct. 28, 2013 - PR Newswire
(0)
(0)